Cassava Sciences settles securities class action for $31.25M

FILANA THERAPEUTICS, INC.

Company to pay $31.25M into escrow in January 2026 to settle consolidated securities class action.
Settlement covers claims from September 14, 2020 to October 12, 2023; releases all named defendants.
Company had previously recorded a $31.25M loss contingency in Q2 2025 for this litigation.
Settlement is not an admission of fault; formal stipulation to be filed for court approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.